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Since the first United Nations High-Level 
Meeting (UN HLM) on NCDs in 2011, the 
NCD community has been able to point 
to many successes on the global stage: 
Noncommunicable Diseases (NCDs) are 
recognised as the world’s biggest killer and 
cause of disability, constituting a global 
health crisis that requires an urgent policy 
response. This was acknowledged by world 
leaders at three UN HLMs on NCDs, meriting 
a dedicated target in the Sustainable 
Development Goals (SDGs) for 2030. 
1 “25 by 25” targets: The WHO Global Action Plan for the Prevention and Control of NCDs 2013-2020 (WHA resolution WHA66.10) includes nine 
voluntary global targets, including a 25% relative reduction in premature mortality from NCDs by 2025; SDG 3.4: A one-third reduction, relative to 
2015 levels, in the probability of dying between 30 years and 70 years of age from cancers, cardiovascular diseases, chronic respiratory diseases, 
and diabetes by 2030.
2 NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. 
The Lancet. 22 September 2018. Available at: http://www.ncdcountdown.org/publications.html (accessed 27 November 2019).
3 NCD Countdown 2030: 35 (19%) for women and 30 (16%) for men.
4 NCD Countdown 2030: 50 (27%) countries for women and 35 (19%) for men.
5 NCD Countdown 2030: 86 (46%) countries for women and 97 (52%) for men.
6 NCD Countdown 2030: 15 (8%) countries for women and 24 (13%) for men.
7 NCD Alliance network survey. 2019.
And yet, almost ten years after the first UN HLM on NCDs 
and five years after adoption of the SDGs, leaders have 
not yet followed up on their international commitments. 
The promises made at the UN to meet targets for 2025 
and 20301 have not translated to necessary action at 
home. 
According to NCD Countdown 2030,2 at the current slow 
rate of progress, SDG target 3.4 to reduce premature 
death between 30-70 years of age from the major NCDs 
will only be achieved by fewer than one-fifth of countries 
by 2030.3 Most of these are high-income countries 
which already have low NCD mortality, and countries in 
Central and Eastern Europe which have made more rapid 
progress. An additional 35-50 countries4 could meet the 
2030 target if action is stepped up. But half of all countries 
(86-97 countries5) are far off track, and need urgent policy 
action to reverse current mortality trends. Alarmingly, the 
first NCD Countdown report shows that premature NCD 
death rates have stagnated or increased since 2010 for 
women in 15 countries and for men in 24 countries.6
A 2019 NCD Alliance survey of national and regional 
NCD alliances reflects this reality: only 20% of alliances 
believe that their country is on track to meet either the 
2025 or 2030 NCD targets, considering current NCD 
prevention and control policies.7 This reflects both the 
failure to tackle the major NCD risk factors – tobacco, 
alcohol, unhealthy diet, lack of physical activity and 
air pollution – as well as the disappointing progress on 
delivering universal health coverage (UHC). For example, 
just two countries, Brazil and Turkey, have implemented 
all five of the tobacco demand reduction measures from 
the Framework Convention on Tobacco Control. Only 
a small minority of national health systems worldwide 
currently have the capacity to provide the necessary 
treatment and care for everyone living with NCDs. Only 
one-third of countries, for example, provide drug therapy 
and counselling to prevent heart attacks and strokes; and 
just 40% of countries provide palliative care in primary 
healthcare or in the community. A vast majority of people 
living with NCDs globally cannot access the care they 
need, either due to lack of availability or because it is 
locally unaffordable. 
The NCD mortality figures do not tell the whole story 
of the global NCD burden. The figures – only capturing 
deaths and only relating to cardiovascular disease, 
cancer, respiratory diseases and diabetes – conceal a 
much larger number of people living with many different 
NCDs worldwide, including mental health conditions, 
and fail to capture deaths under 30 or over 70 years. 
For example, 3.5 billion people worldwide live with the 
potential debilitating impacts of untreated tooth decay 
and other oral health conditions, but are excluded from 
measures of NCD progress.8 
As a result of these hollow promises and inaction, the 
NCD epidemic continues to cut lives cruelly short and 
cause unnecessary pain and hardship. NCDs are an 
indiscriminate killer, but disproportionately affect the 
poorest countries in the world and the poorest people 
in every country. Inaction is exacerbating inequality. 
NCDs are responsible for 71% of deaths globally, which 
represents over 41 million people killed by NCDs every 
year. 15 million of these people are under 70 years old, 
including 8.5 million people in lower and lower-middle 
income countries.9 The outrage is that the majority of 
this death and suffering, the impact on families and 
communities all over the world, is preventable. 
Thanks to decades of research, policy development and 
country experience, the recipe for success has been 
tried-and-tested. Governments know what needs to be 
done. They know which policies will make a difference 
to the lives of people living with and at risk of NCDs. And 
they know that, if done well, implementing recognised 
‘best buy’ policies saves money as well as lives. So, after 
ten years of experience, we have to ask: what’s stopping 
them?
8 Watt Richard G Prof et al. Ending the neglect of global oral health: time for radical action. The Lancet. 20 July 2019. Available at: https://www.
thelancet.com/journals/lancet/article/PIIS0140-6736(19)31133-X/fulltext
9 Bertram, M. et al. Using economic evidence to support policy decisions to fund interventions for NCDs. BMJ. June 2019. 365: 1648.
This paper outlines the gaps in the first decade of 
the NCD response. Calling on the experience of NCD 
Alliance’s global network of people living with NCDs, 
advocates, campaigners and experts collected via 
several surveys, as well as the latest data from the 
World Health Organization and peer reviewed literature, 
the following pages identify what has been lost in 
translation of the global targets for NCD reduction and 
describe the major barriers to meaningful progress. 
The five gaps identified here – Leadership, Investment, 
Care, Community Engagement, and Accountability – are 
not exhaustive and are intended as the basis for strategic 
debate. The gaps identified are based on survey data 
gathered from national and regional NCD alliances, 
who cite inter alia lack of political will and leadership, 
lack of financial resources, lack of government staff 
capacity / technical expertise, industry interference, and 
insufficient accountability mechanisms as key barriers 
limiting governments from scaling up NCD actions. The 
gaps highlighted are intended as focus areas to fast-
track future action within the framework of sustainable 
development, going beyond the NCD community and 
beyond the health sector to mainstream NCDs at the 
level of political and public attention that they merit. 
We are just five years away from 2025 and a fourth UN 
meeting of world leaders on NCDs. We must dramatically 
accelerate the response and change course in order 
to achieve significant and sustainable progress, and to 
make sure that more people, more communities and 
more families are spared the pain and cost of NCDs by 
2030. 
Following each gap described here, actions for civil 
society are proposed that can potentially bridge the gaps 
to change the future for people living with and at risk of 
NCDs. These are synthesised into the NCD Civil Society 
Compass as a proposal for further NCD community 
development, discussion and action.
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NCDs are a challenge beyond the health 
sector. The causes, impacts and solutions 
are often beyond the remit and influence of 
Ministries of Health, and therefore require a 
whole-of-government and whole-of-society 
response, including economic and societal 
actors. For this reason, leadership of the NCD 
response needs to come from the Heads 
of State or Government to achieve impact, 
as emphasised by the WHO Independent 
High-Level Commission on NCDs and Mental 
Health.10 This is essential to tailor the national 
response, avoid duplication, manage potential 
conflicts of interest, navigate trade-offs, and 
ensure coherence in policies in order to meet 
national NCD targets.
10 WHO Second report of the Independent High-Level Commission on NCDs and Mental Health. 2019. Available at: https://www.who.int/ncds/
governance/high-level-commission/en/
11 United Nations General Assembly [Resolution]. Political declaration of the third high-level meeting of the General Assembly on the prevention and 
control of non-communicable diseases. 2018. Available at: https://www.un.org/en/ga/search/view_doc.asp?symbol=A/RES/73/2
12 e.g. the TAPIC framework http://www.euro.who.int/__data/assets/pdf_file/0012/416100/PolicyBrief_PB33_TAPIC.pdf?ua=1
13 Countries were not yet asked to report on the status of updating plans to the “5 by 5 approach” to include mental health and air pollution.
Political leadership
To date, too few national leaders have had the vision to 
lead the fight against the world’s biggest killer and cause 
of disability, simultaneously putting their economies on a 
more sustainable path. There have been some valuable 
exceptions: The Caribbean Community (CARICOM) 
leaders who signed the Port of Spain Declaration in 
2007, which kicked off the movement for global NCD 
action; the Pacific Islands leaders who convened the 
first Pacific NCD Summit in 2016; and the Presidents of 
Uruguay, Finland and Sri Lanka, who were among the co-
chairs of the WHO Independent High-Level Commission 
on NCDs. At the UN HLM in 2018, Heads of State and 
Government reiterated their commitment to provide 
strategic leadership by promoting policy coherence and 
coordination through whole-of-government and health-
in-all-policies approaches.11 The sections below outline 
priorities to take this commitment forward. 
Good governance and policy 
coherence for health
Good governance relies on effective governing 
frameworks12 rooted in transparency, accountability and 
participation of all affected, and should result in policy 
coherence. Transformative leadership takes different 
shapes in different parts of the world, but there are 
common failings, which can be traced back to poor 
governance affecting the ability of policy-makers to 
take evidence-based decisions, implement policies and 
ensure alignment between different sectors. 
The number of countries with established national NCD 
plans and targets in place is a valuable indicator of good 
governance and political leadership. In 2019, 57% of 
countries reported to WHO having an integrated multi-
sectoral national plan in place for NCDs which addresses 
the four main NCDs and four main risk factors.13 Two-
thirds of countries reported national targets in place for 
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NCD reduction by 2025. Absence of coordinated multi-
sectoral action has been identified as a key barrier to 
NCD action.14 Less than half of countries have a multi-
sectoral commission on NCDs in operation, and it is 
notable that 30% of these do not include civil society. Top-
level leadership is essential for prioritisation, to ensure 
coordination towards the common national NCD plan, a 
single set of NCD targets, and one national coordinating 
authority (the so-called ‘Three Ones’ principles, as 
pioneered in the HIV/AIDS response)15 
The concepts of ‘health in all policies’ and ‘governance 
for health’ mean that decisions made in other policy areas 
must not harm public health. But they have too seldom 
been put into practice. Some rare beacons include 
governments in Finland, Norway and Wales who are 
obliged to undertake wellbeing impact assessments for 
proposals across all policy areas. Current governments 
in Iceland, Scotland and New Zealand pride themselves 
on being ‘Governments for Wellbeing’, providing an 
instructive model from the top of government for a public 
health ethos at the heart of their policy programmes and 
national budgets.
In the context of health systems development, availability 
and affordability of care and treatment, it is noted that 
“corruption is embedded in health systems”16 and remains 
a major obstacle to health in every region.17 The highest 
level of leadership is essential to root out corruption to 
secure necessary resources for health. It is estimated 
that “each year, corruption takes the lives of at least 
140 000 children, worsens antimicrobial resistance, and 
undermines all of our efforts to control communicable 
and non-communicable diseases.”18 The hundreds of 
14 Tuangratananon, T, Wangmo, S et al. Implementation of national action plans on noncommunicable diseases, Bhutan, Cambodia, Indonesia, 
Philippines, Sri Lanka, Thailand and Viet Nam. Bulletin of World Health Organisation. February 2019. 97(2): 129–141. doi: 10.2471/BLT.18.220483. 
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357573/
15 UNAIDS. Three Ones: Key Principles.2004. Available at: http://data.unaids.org/una-docs/three-ones_keyprinciples_en.pdf
16 Garcia P.J, MD. Corruption in global health: the open secret. The Lancet. 27 November 2019. Available at: https://www.thelancet.com/journals/lancet/
article/PIIS0140-6736(19)32527-9/fulltext?dgcid=raven_jbs_etoc_email
17 Transparency International. How corruption weakens democracy. 2019. Available at: https://www.transparency.org/news/feature/cpi_2018_global_
analysis
18 Garcia P.J, MD. Corruption in global health: the open secret. The Lancet. 27 November 2019. Available at: https://www.thelancet.com/journals/lancet/
article/PIIS0140-6736(19)32527-9/fulltext?dgcid=raven_jbs_etoc_email
19 Transparency International. The ignored pandemic. 2019. Available at: http://ti-health.org/content/the-ignored-pandemic/; Jain A, Nundy S, Abbasi 
K. Corruption: medicine’s dirty open secret. BMJ. 2014. 348g4184; WHO. Global health expenditure database. 2019. Available at: http://apps.who.int/
nha/database; Deloitte. 2019 global health care sector outlook. 2018. Available at: https://www2.deloitte.com/global/en/pages/life-sciences-and-
healthcare/articles/global-health-care-sector-outlook.html
20 The World Bank. High-performance financing for universal health coverage: Driving sustainable, inclusive growth in the 21st century. June 2019. 
Available at: http://documents.worldbank.org/curated/en/641451561043585615/Driving-Sustainable-Inclusive-Growth-in-the-21st-Century; Jones B, Jing 
A. Prevention not cure in tackling health-care fraud. Bull World Health Organisation. 2011. 89: 858-859.
21 Vital Strategies. Fool me Twice. 2017. Available at: https://www.vitalstrategies.org/resources/fool-twice-ncd-advocacy-report/
22 Tangcharoensathien, V. et al. Addressing NCDs: Challenges From Industry Market Promotion and Interferences. International Journal of Health Policy 
and Management. January 2019. Available at: http://www.ijhpm.com/article_3589_973ade641b38c90db565007c74e72f47.pdf
billions of dollars stolen each year from health systems 
(estimated to be at least 10-25% of US$7.5 trillion in global 
health spending19) exceed WHO estimates of the funding 
needed to reach UHC globally by 2030.20 
Unhealthy industry interference
National leaders must ensure that citizens’ wellbeing 
is prioritised above short-term aims and signal across 
government how to deal with conflicting demands from 
different sectors. Strategic interference from unhealthy 
commodity industries who see their vested interests 
threatened by NCD prevention policies is a well-
documented challenge.21 Interference by the alcohol, food 
and beverage industries has been persistent throughout 
negotiation of global policy development to prevent 
NCDs.22 According to the survey of national and regional 
NCD alliances, just 7% believe that their government has 
efficient mechanisms to manage conflicts of interest in 
health policy and NCD decision-making processes. 
Bridging the Gap on NCDs: From global promises to local progress | 7
THE  LEADERSHIP GAP
6 | Bridging the Gap on NCDs: From global promises to local progress
Incompatible partnerships 
The Sustainable Development Goals call for an “integrated and indivisible approach”, breaking down the siloes between 
goals and issues for win-win solutions for societal, economic and environmental gain. In order to achieve this, partnerships 
in the SDG era need to be aligned and coherent with all goals, including health and NCD prevention. There is, however, a 
worrying trend of incompatible partnerships between multilateral agencies and unhealthy commodity industries (alcohol, 
big soda, tobacco, fossil fuels), which are blindly focusing on one issue, whilst putting other health goals at risk.
It is inappropriate for global health organisations to partner with companies whose products cause harm to health and 
have devastating track records of subverting science and undermining public policies to protect health. It became crystal 
clear at the time of the Global Fund to Fight AIDS, Tuberculosis and Malaria’s proposed partnership with Heineken23, 
given alcohol’s role as a risk factor for the transmission of sexually transmitted diseases, NCDs, mental health issues 
and violence, that there cannot be a place for alcohol in partnership for the health goals and SDGs as a whole.24 The 
same can be said for Coca-Cola, who intensively lobbies against the protection of children from obesogenic advertising, 
provision of clear, unbiased information to consumers, and the introduction of health taxes. 
The false promise of ‘self-regulation’ 
Health-harming industries should have no role in the development of national or international NCD policy: “Despite the 
common reliance on industry self-regulation and public–private partnerships, there is no evidence of their effectiveness 
or safety. Public regulation and market intervention are the only evidence-based mechanisms to prevent harm caused by 
the unhealthy commodity industries.”25
This conclusion is confirmed by experiences across the NCD Alliance global network. Many NCDA members have engaged 
with self-regulatory platforms and voluntary industry commitments. There are numerous examples in the area of healthier 
diets and alcohol harm reduction which have collapsed because of failure to deliver, including the Responsibility Deal in 
England26, the Mexican Observatory on NCDs (Observatorio de ENT)27, alcohol advertising self-regulation in Australia28, 
the EU Forum on Alcohol and Health29, and the EU Platform for Diet, Physical Activity and Health.30 
23 Hodal, Kate. Not remotely refreshing: global health fund criticised over Heineken alliance. The Guardian. 2 February 2018. Available at:  
https://www.theguardian.com/global-development/2018/feb/02/global-health-fund-rebuked-over-heineken-alliance-aids-tuberculosis-malaria).
24 Vital Strategies, NCD Alliance, IOGT International, Global Alcohol Policy Alliance. Trouble Brewing. 2018. Available at: https://troublebrewingreport.
org/the-alcohol-industry.
25 Moodie, R., Stuckler, D., Monteiro, C., Sheron, N., Neal, B., Thamarangsi, T., et al. Profits and pandemics: prevention of harmful effects of tobacco, 
alcohol, and ultra-processed food and drink industries. The Lancet. 2013. Available at: https://www.thelancet.com/journals/lancet/article/
PIIS01406736%2812%2962089-3/fulltext
26 Knai, C. Petticrew, M. et al, The Public Health Responsibility Deal: Using a Systems-Level Analysis to Understand the Lack of Impact on Alcohol, Food, 
Physical Activity, and Workplace Health Sub-Systems. International Journal of Environmental Research and Public Health. December 2018. Available 
at: https://researchonline.lshtm.ac.uk/id/eprint/4650838/1/Knai-etal-2018-The-Public-Health-Responsibility-Deal.pdf
27 UK Health Forum 2018. Public health and the food and drinks industry: The governance and ethics of interaction. Lessons from research, policy and 
practice. 2018. Available at: https://www.idrc.ca/sites/default/files/sp/Documents%20EN/ukhf-casebook-jan18.pdf
28 Jones, S. C., Hall, D., Munro, G. How effective is the revised regulatory code for alcohol advertising in Australia? Drug Alcohol Review. 2008.  
27: 29–38.
29 de Coninck, P. and Gilmore, I. Long overdue: a fresh start for EU policy on alcohol and health. The Lancet. 16 December 2019. Available at: https://doi.
org/10.1016/S0140-6736(19)33103-4  
30 BEUC et al. Statement: Civil society organisations leave the EU Platform for Diet, Physical Activity and Health. 2019. Available at: https://www.beuc.eu/
publications/beuc-x-2019-039_statement_on_leaving_platform.pdf 
31 Jacobs, A. and Richtell, M. She Took on Colombia’s Soda Industry. Then She Was Silenced. New York Times. 13 November 2017. Available at: https://
www.nytimes.com/2017/11/13/health/colombia-soda-tax-obesity.html
32 Perlroth, Nichole. Spyware’s Odd Targets: Backers of Mexico’s Soda Tax. New York Times. 11 February 2017. Available at: https://www.nytimes.
com/2017/02/11/technology/hack-mexico-soda-tax-advocates.html?mcid=nyt-es&subid=article&ref=nyt-es&subid=article.
33 The Healthy Caribbean Coalition has advanced work on how to manage conflict of interest in the Caribbean. A recent comprehensive report on the 
matter is available: https://www.healthycaribbean.org/wp-content/uploads/2019/09/Managing-Conflict-of-Interest-for-NCD-Prevention-and-Control-in-
the-Caribbean-WEB.pdf
34 Collin et al (2017) conclude that given the widespread recognition that the interests of alcohol and food manufacturers fundamentally conflict with 
public health objectives, “it seems clear that health governance and research require more coherent approaches to the terms with which they engage 
with unhealthy commodity producers. This could involve examining how the adaptation of tobacco control practices and norms, including those 
arising from [FCTC] Article 5.3, might inform measures to improve transparency and governance across NCD policy debates.”
35 Collin, Jeff; Hill, Sarah E.; Eltanani, Mor Kandlik; Plotnikova, Evgeniya; Ralston, Rob; Smith, Katherine E. Can public health reconcile profits and 
pandemics? An analysis of attitudes to commercial sector engagement in health policy and research. PLoS One. 2017. Available at: https://www.ncbi.
nlm.nih.gov/pmc/articles/PMC5590731/
NCD CIVIL SOCIETY COMPASS
Demand leadership and coherence for health
Civil society should request that national leaders establish NCD coordination mechanisms to deliver 
on national targets. CSOs and academia can also carry out Health Impact Assessments of proposals in 
other policy areas, importantly including international trade policies. 
Monitor industry interference and raise awareness
Many national and regional NCD alliances31, 32 play a crucial role in addressing industry influence. Civil 
society, supported by academic research and progressive media, can significantly advance global and 
national discussions by raising awareness of incompatible partnerships and health-harming tactics to 
influence policy-makers.
Develop guidance on private sector engagement 
In relation to engagement with the private sector including partnerships, national governments are 
requesting guidance on how to identify and manage potential and real conflict of interest, interference 
and corporate capture, and ensure that the public good is the bottom line. Civil society can work together 
with WHO or the UN to develop such guidance.33, 34, 35
Adapt to work with different political administrations
To keep the NCD response moving forward and ensure health-supporting policies are not rolled back, 
civil society organisations must find ways to engage all parties across the political spectrum and 
demonstrate public support for policies in force. 
Develop future leaders from the NCD movement 
We must continue making the case to today’s politicians. But the NCD movement can also shape and 
inspire future leaders. Today’s young NCD voices will soon become the next generation of decision-
makers and leaders, not only in health, but across all sectors. If our current crop of politicians is unwilling 
to become NCD champions, we have to grow our own.
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In recent years, the NCD community has 
made a conscious shift from talking about 
health expenditure to talking about health 
investment. For too long, NCD action has 
been branded as an expenditure, when many 
of the ‘best buy’ policy actions are in fact 
low cost, affordable for every country, and 
represent a smart and strategic investment. 
In low- and middle-income countries (LMICs), 
for every dollar invested in NCDs, there is a 
return to society of at least US$7 in increased 
employment, productivity and longer life. 
Annual GDP losses range from 3.5% - 5.9%, 
costing LMICs alone US$7 trillion between 
2011 and 2025,36 which is equivalent to 
the combined GDP of France, Spain and 
Germany. The bottom line for governments 
is clear: invest now, save later. The return 
on investment in NCD action significantly 
outweighs the costs.
36 WHO. Scaling up action against non communicable diseases: how much will it cost? 2011. Available at: http://www.who.int/nmh/publications/cost_of_
inaction/en/ 
37 Institute for Health Metrics and Evaluation (IHME). Financing Global Health 2015: Development assistance steady on the path to new global goals. 2016.
38 Institute for Health Metrics and Evaluation (IHME). Financing Global Health 2018: Countries and Programs in Transition. 2019. 
39 Global Health Action. Financing national non-communicable disease responses. 2017. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC5496084/#CIT0019
Over the past decade, funding for NCDs and global 
health has been at the forefront of international policy 
discussions and meetings. In 2011, at the first UN HLM on 
NCDs, world leaders committed to explore the provision 
of ‘adequate, predictable and sustained resources’ 
through various channels, and the commitment was 
reiterated in the 2014 UN High-Level Review on NCDs. 
The adoption of the 2015 Addis Ababa Action Agenda 
on Financing for Development recognised that taxation 
of tobacco could represent a source of revenue for 
countries and reduce consumption, providing a means to 
achieve SDG target 3.4 on NCDs by 2030. At the third 
UN HLM on NCDs in 2018, world leaders committed to 
accelerate their responses within the context of the SDGs. 
And, in 2019, the Political Declaration of the UN HLM on 
UHC recognised price and tax measures as a potential 
revenue stream for governments that also reduces 
consumption, and therefore NCD prevalence, which is an 
important component of the NCD response. 
And yet, despite the catastrophic global burden of NCDs 
and the numerous global commitments, the proportion of 
total global health financing dedicated to prevention and 
treatment has remained at an abysmal 1-2% for nearly 
twenty years.37 The latest data shows that in 2018, US$778 
million, or just 2% of development assistance for health 
(DAH), was allocated to NCDs.38 This lack of attention to 
funding NCDs occurs at all levels: international, regional, 
and national. At the domestic level, only half of all 
governments included NCD line items in their budgets 
in 2011, and this number has not significantly increased 
since then.39 This is a far cry from the investment needed 
to translate global commitments into transformative 
national action. 
Closing the resource gap for NCDs will require multiple 
financing sources tailored to each country’s disease 
burden and epidemiological conditions, fiscal capacity, 
donor relationships, strength of the private sector, and 
other factors. The expected result will be a “blended” 
stream of financing, including creating and optimising 
fiscal space for NCD investment domestically, exploring 
novel financing mechanisms (including taxation of 
unhealthy commodities such as tobacco, alcohol, sugary 
drinks and fossil fuels), multilateral/bilateral funding, 
private sector engagement, and catalytic mechanisms. 
Many of these streams remain untapped for NCDs at 
global and national levels. 
The financing gap: Where will the 
money come from? 
International donors are still heavily focused on 
funding specific diseases and conditions aligned with 
the Millennium Development Goals (MDGs), instead 
of shifting to the more comprehensive targets outlined 
in the Sustainable Development Goals (SDGs), thus 
overlooking NCDs. Using IHME’s 2015 Global Burden of 
Disease study and 2016 Financing Global Health report 
(excluding funding for NCDs, where RTI’s estimate was 
used instead of IHME’s), calculations for dollars spent 
per attributable disability-affected year of life (DALY) 
were collected on NCDs, maternal disorders, neonatal 
disorders, tuberculosis, HIV/AIDS, and malaria for 2015. 
NCDs represent the biggest burden worldwide, but 
received the lowest funding by far, with US$ 0.79 billion 
per DALY compared to maternal disorders (US$ 309.33), 
HIV/AIDS (US$ 166.41), neonatal disorders (US$ 44.33), 
malaria (US$ 42.67), and tuberculosis (US$ 32.89) (see 
Figure 1 below).
40 WHO. NCD Country Capacity Survey. 2019. Available at: https://www.who.int/ncds/surveillance/ncd-capacity/en/ 
41 ibid.
To tackle the high burden of NCDs, mobilising domestic 
resources will be crucial for all countries. Domestic 
financing for NCDs includes ensuring that the NCD 
response is included in national annual budgets for 
health, as well as implementing policies such as taxation 
of unhealthy commodities and the phasing out of 
subsidies for health-harmful products, which can provide 
a significant source of revenue for governments. Data 
from the latest WHO Country Capacity Survey on NCDs 
indicates that only 38% of countries have implemented 
taxes on sugar-sweetened beverages and only 6% on 
high fat, sugar, and salt foods – however, the number 
of countries implementing these policies has increased 
significantly over recent years. A growing number of 
countries are also earmarking tax revenues (46%) for 
the NCD response.40 National health spending was most 
prevalent for health care and treatment (90% of countries), 
followed by health promotion activities (88%), primary 
prevention (88%), early detection and screening (87%), 
surveillance, monitoring and evaluation (84%), capacity 
building (79%), palliative care (68%), and research (65%).41 
While these figures suggest that countries are adequately 
funding the NCD response, the reality on the ground 
is regrettably different (see also the Care gap below). 
Not nearly enough is being done to implement health-
promoting fiscal measures, and more focused attention 
is needed on funding NCD-specific programmes and 
policies as part of UHC.
Figure 1: Funding (US$bn) compared to disease burden (disability affected lifeyears (DALY) for global health priorities. Graph from 
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Though domestic resource mobilisation is an important 
component of financing NCDs, there is still a large gap 
that the international community needs to fill, and DAH 
will remain catalytic for countries currently allocating 
less than 5% of their GDP to health. A valuable new 
initiative from the Norwegian government42 is a world-first 
health and development strategy focused on combatting 
NCDs. However, while some development agencies, 
including from the UK, USA, Sweden, and Australia, 
are supporting NCDs as part of other programmes 
(for example, via health system strengthening efforts, 
integrating NCDs into existing global health programmes, 
or tobacco control programmes in low- and middle-
income countries), overall, they have not yet taken on 
NCDs specifically and have remained non-committal. 
Another avenue for funding NCDs is ensuring they are 
integrated into associated aid instruments at country 
level, including budget support, Sector Wide Approaches 
(SWAps), Poverty Reduction Strategy Papers (PSRPs), 
and UN Development Assistance Frameworks (UNDAFs). 
Under the auspices of the UN Interagency Task Force 
on NCDs, WHO and UNDP are now providing technical 
support to low- and middle-income countries (LMICs) to 
integrate NCDs into UNDAF design and implementation. 
Yet, according to a recent review of UNDAFs rolled out 
in 2014-2015, only 20 out of 54 UNDAFs included NCDs 
(37%), demonstrating that NCDs are still not sufficiently 
represented in development planning processes at the 
country level. 
Development of innovative financing instruments had 
been expected to support the transition from MDGs to 
SDGs, including the NCD response. But so far, around 
98% of the funding raised for innovative instruments has 
remained disease specific and linked to the MDG health 
targets – there has been no “grand convergence in health” 
as advocated by the Lancet Commission in Investing in 
Health.43 This urgently needs to change, with all donors 
in the global health architecture (including governments, 
agencies, and philanthropies) considering how to 
integrate NCDs into their programmes, implementing 
innovative, catalytic funding mechanisms and instruments 
to better respond to people’s health needs rather than 
just individual diseases. Figure 2 shows that the majority 
of funding for NCDs comes from the non-profit sector, 
and there is a need for both international donors and 
governments to step up their response. 
42 Norwegian Ministry of Foreign Affairs and Norwegian Ministry of Health and Care Services. Better Health, Better Lives. 2019. Available at: https://www.
regjeringen.no/globalassets/departementene/ud/vedlegg/utvikling/betterhealth_summary.pdf
43 Jamison, D. Summers; L., Alleyne G.; et al. Global Health 2035: a world converging within a generation. Lancet Commission on Investing in Health. 
2013. 382: 1898-995.
The data gap 
There is an urgent need for more and better data on 
resource flows for NCDs. Current data on domestic 
financing is almost non-existent, in part due to the 
absence of NCDs in National Health Accounts, and the 
challenge of tracking expenditure across all government 
departments. Important lessons could be drawn from 
the climate change community, with Climate Public 
Expenditure and Institutional Reviews (CPEIRs) providing 
valuable analyses of the allocation and management of 
public expenditures across all government departments 
and guiding strategic investments. Some progress has 
been made, with the inclusion of a purpose code for NCDs 
in the OECD Creditor Reporting System (CRS), which will 
begin reporting in 2020. It will be important to make data 
surveillance, monitoring, collection, and evaluation more 
systematic. 
Advocate for international donors to support smart investments in prevention 
interventions and health systems strengthening
Investments can be designed to encourage domestic resource mobilisation, and should consider how 
to galvanise efficiency improvements and include stringent monitoring and evaluation, so as to avoid 
creating dependence and to maximise public benefit for the investment.
Advocate for governments to include NCDs in their national health budgets and plans
National and regional NCD alliances can work with governments to integrate NCDs, multi-morbidity, 
health system strengthening, and health workforce capacity into their national plans and proposals to 
international donors. 
Advocate for governments to phase out subsidies and implement taxation of unhealthy 
commodities (sugar, tobacco, alcohol, fossil fuels) and use funds to support health systems 
strengthening, particularly for NCDs
Health-promoting fiscal measures can decrease consumption and provide a source of revenue for 
governments to reinvest in their health systems. Civil society engagement can be instrumental in 
mobilising public support for recommended measures and holding governments to account. 
Increase national civil society participation in country missions of the UNIATF, including 
preparing and promoting investment cases
Engagement of civil society in preparation and follow-up of missions and investment cases significantly 
increases chances of successful implementation. Civil society can provide important perspectives of the 









Figure 2: Sources of global NCD funding, 2015-2019. Rachel 
Nugent et al. Figures provided by Rachel Nugent/RTI.
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The Investment Gap
Faced with a lack of external investment for 
NCDs as described here, LMICs have been 
left to respond to increasing burdens of 
NCDs within their own underfunded, weak 
health systems that are not adapted to 
manage chronic diseases. Governments are 
juggling a backlog of common infections, the 
double burden of malnutrition, and maternal 
mortality together with the growing burden 
of NCDs, pandemics and the health impacts 
of climate breakdown. Budgets and health 
systems are crippled by increasing demand, 
meaning that few low-income countries can 
provide care for NCDs in their health benefit 
packages and over 60% of people living 
with NCDs (PLWNCDs) have experienced 
catastrophic health expenditure. 
Whilst the Political Declaration of the UN High-Level 
Meeting on UHC in 2019 represents significant progress 
in global leaders’ commitment to ‘Health for All’, 
including commitment to provide financial protection, and 
governments have set a global target for 80% availability 
of essential medicines and technologies for NCDs in 
public facilities, there is a vast gap that must be bridged to 
reach that goal by 2030. Only 46% of countries have set 
national targets related to health systems and treatment 
for the four main NCDs, as data does not yet include 
mental health conditions. Today, over half the world’s 
population still cannot access essential health services, 
and an estimated 100 million people worldwide are still 
into extreme poverty every year by their healthcare 
needs. Much of this will be due to the cost association 
with living with one or more NCDs. 
Inequitable access to NCD 
medicines and technologies
Once diagnosed with an NCD, an individual can face 
many hurdles in accessing treatment and care. Access 
to essential medicines and technologies for NCDs is 
often poor in many LMICs. In many countries, medicines 
for NCDs are not available when needed, and if they are 
available, are unaffordable for people living with NCDs. 
Low availability can be caused by a lack of sufficient 
and sustainable public resources or under-budgeting, 
inaccurate demand forecasting, poorly managed supply 
chains, and inefficient procurement and distribution. This 
often forces people seeking treatment to the private 
sector, where generic medicines are sometimes two to 
three times more expensive, causing further financial 
strain on household budgets. When medicines are 
available, the quality and safety may sometimes be 
in question, and there are a rising number of cases of 
counterfeit medicines for NCDs to fill the gap of insufficient 
public sector availability of essential medicines. 
Ensuring availability of affordable, safe, quality NCD 
medicines is an important component of achieving 
universal health coverage, and requires health systems 
strengthening, efficient procurement and distribution 
of medicines, and monitoring and evaluation of both 
availability and affordability. According to the 2020 
WHO NCD Country Capacity Survey, only 34% of 
countries are providing the full range of drug therapy and 
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counselling to prevent heart attacks and strokes, while 
only 39% provide palliative care in primary health care 
facilities. This snapshot of just two aspects of the NCD 
response demonstrates that, despite numerous global 
commitments, there is still a long way to go to deliver. 
Ensuring the availability and affordability of essential 
NCD medicines and technologies is only one piece of 
solving the broader access challenge. In many countries, 
there is strongly ingrained stigma and discrimination 
against certain NCDs, reducing the likelihood that people 
will seek out diagnosis and treatment for a condition that 
may result in a negative social label. When medicines, 
technologies, and services are available, many people in 
LMICs must travel far distances to their local health facility, 
resulting in an additional hardship, especially for women 
who are often the primary caregivers in their homes and 
unable to transfer the duties to another family member. 
For those that are able to reach the health facility, there 
must be a well-equipped and trained health workforce, 
able to manage NCDs throughout the lifecourse as well 
as the increasing prevalence of multi-morbidities.
Inadequate health workforce for 
the NCD challenge
The growing burden of NCDs and shifting demographics 
will generate demand for an additional 40 million health 
workers globally by 2030, requiring that the global 
health workforce essentially doubles in order to avoid 
an estimated shortfall of 18 million workers. This shortage 
is a significant challenge to the sustainability of primary 
healthcare and the achievement of UHC. And for people 
living with NCDs, continuous access to well-trained and 
resourced health care workers is essential to adequately 
manage their disease(s) and help optimise their physical 
and mental health and wellbeing. The distribution of 
health providers is problematic across all countries of 
all income levels. Especially notable is the shortage of 
health workers in rural areas – more health workers are 
present in urban areas, making it difficult for those in 
rural areas to reach health care services. There is also 
a disproportionate shortage of health workers in LMICs, 
which is far more severe than in higher-income countries. 
Reorienting health systems  
for chronic conditions and health 
for all 
Historically, health systems have been designed on 
a “disease model” that focuses on treating illnesses 
as and when they arise, instead of focusing on them 
at the primary health care level, prioritising health 
promotion and disease prevention and responding to 
the lived experience and views of patients. This model 
has been effective in treating infectious diseases and 
maternal and child mortality, but has not addressed the 
treatment and care of chronic conditions. As the burden 
of disease shifts and the prevalence of multi-morbidity 
increases, health systems are inadequately prepared 
to respond effectively. Many NCDs are not present in 
isolation – people with NCDs are often living with one 
or more conditions, including mental health conditions 
such as depression and anxiety. This also holds true 
for people living with infectious diseases such as HIV 
and tuberculosis, which often results in a higher risk of 
developing certain NCDs. 
Health systems that are responsive to and prepared for 
chronic care prevention, treatment, and management link 
people with proactive health care teams that are well-
trained and resourced to provide person-centred care. 
Continuous monitoring, surveillance, and evaluation is 
necessary to track outcomes and ensure that systems 
are efficiently and effectively meeting the needs of the 
populations they are meant to serve. 
ADDITIONAL RESOURCES: 
More challenges and solutions, as well as case 
studies, are available in the NCD Alliance’s report 
Protecting Populations, Preserving the Future: 
Optimising the health workforce to combat NCDs 
and achieve UHC.
Recommendations and case studies of how to 
overcome barriers to more integrated models of 
care are available in the NCD Alliance’s report 
Shaping the Health Systems of the Future.
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THE COMMUNITY 
ENGAGEMENT GAP 
Momentum in several health and sustainable 
development issues, notably HIV/AIDS, 
Ebola and climate change, have repeatedly 
reinforced the critical role of civil society 
organisations (CSOs) and community-led 
efforts in accelerating action from local 
to global levels. Civil society actors are 
proven demand creators, mobilisers and 
campaigners, change agents, innovators, 
experts, implementers, and watchdogs. 
However, a long-standing gap for the NCD 
response is that the international community 
and governments have been slow to 
recognise and meaningfully involve CSOs in 
the response. 
44 Office of the United Nations High Commissioner for Human Rights. The Right to Health. Available at: https://www.ohchr.org/Documents/Publications/
Factsheet31.pdf
45 Office of the United Nations High Commissioner for Human Rights. International Covenant on Economic, Social and Cultural Rights. Available at: 
https://www.ohchr.org/EN/ProfessionalInterest/Pages/CESCR.aspx
46 Patterson, D.; Buse, K.; Magnusson, R.; Toebes, B. Identifying a human rights-based approach to obesity for states and civil society. Obesity Reviews. 
2019. 20( S2): 45– 56.
47 These include the WHO Global NCD Action Plan, the WHO Report of the Commission on Ending Childhood Obesity, which links to the United Nations 
Convention on the Rights of the Child, United Nations Global Strategy for Women’s, Children’s and Adolescent Health, and most recently the 2018 
United Nations General Assembly Political Declaration on NCDs.
The lack of a rights-based, 
equitable response
Inaction on NCDs is fundamentally a failure to respect 
people’s basic right to enjoyment of the highest attainable 
standard of physical and mental health, which was 
enshrined in the Constitution of the WHO in 1946, the 
1948 Universal Declaration of Human Rights44, and the 
International Covenant on Economic, Social and Cultural 
Rights.45 Failure to act is exacerbating inequality between 
and within countries. 
Currently, many groups are poorly served by the NCD 
response; risk factors unevenly impact different groups 
in society, and many people living with NCDs are still left 
behind and are unable to access the treatment and care 
they need. People left behind in the NCD response vary in 
each region and country, but frequently include women, 
youth, elderly, religious and racial minorities, LGBT+ 
people, refugees and migrants, Indigenous communities, 
rural or geographically isolated communities, people 
living with disabilities and those with mental health 
conditions. Many of these groups are also protected by 
binding international conventions, for example against 
racial discrimination, for the rights of women, children, 
and people with disabilities, and others. 
The foundation for an explicit, human rights-based 
approach is reflected in key policy documents on NCDs, 
and provides a strong basis for civil society to hold 
governments accountable. 46, 47 
Advocate for governments and donors at national, regional and international levels to 
integrate health systems that meet the needs of people and address the realities  
of multi-morbidity 
Integrated health systems rooted in strong primary health care are necessary to treat people as a 
whole and not in disease siloes, and can deliver better care across the lifecourse. These systems, 
together with a well-trained and resourced health workforce, can also be better prepared to respond 
to the needs of people living with two or more concurrent conditions, and should engage people 
living with NCDs as advisors in health system design and development.
Advocate for governments to include essential, quality, affordable NCD medicines and 
technologies as part of UHC national benefit packages 
Governments must meet the global targets upon which they have agreed and ensure consistent 
availability of essential, quality, affordable medicines and technologies at all levels of health care 
delivery.
Advocate to establish independent accountability mechanisms for UHC 
To date, no independent accountability mechanisms are in place to monitor implementation of UHC 
commitments. These mechanisms must include civil society and people living with NCDs to help monitor, 
track, and evaluate the efficiency and effectiveness of national plans and policies.
Advocate for more robust, disaggregated data to support national targets on health 
systems strengthening, provision of essential NCD medicines and technologies, and 
access to treatment and care 
Better data capturing and reporting systems are necessary for governments, donors, and civil society 
to understand the true burden of disease, including multi-morbidity, how policies are implemented, and 
whether services are utilised by the people most in need. 
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NCD civil society - a crucial force 
to beat NCDs
Civil society organisations are non-state, not-for-profit 
entities formed by people in the social sphere with 
commonly held values, beliefs, or causes.48 Comprising 
non-governmental organisations (NGOs), community 
groups, informal social movements, patient groups, 
consumer groups, women’s groups, indigenous 
community groups, youth organisations, faith-based 
organisations, professional societies, foundations, 
academia, and think tanks, NCD civil society is diverse.49 
National and regional NCD alliances uniting disease 
and risk factor interest groups efficiently and effectively 
coordinate advocacy, reinforce each other’s priorities, 
and amplify efforts to achieve common objectives. Today, 
there are over 65 strong national and regional NCD 
alliances across the world.50 
Civil society has an important agenda-setting role in 
NCDs, raising public demand for policies, laws and action 
and ensuring that services reach communities. Through 
close connection with PLWNCDs and their communities, 
CSOs can provide unrivalled knowledge of the lived 
experience that could otherwise be inaccessible to 
policymakers. They address service gaps for people 
most excluded, and when needed, deliver health-
promoting and lifesaving services. Crucially, CSOs can 
hold governments to account to deliver on promises 
made. The NCD Alliance summarises these roles of civil 
society as the “Four A’s”: advocacy, awareness, access, 
and accountability.
48 WHO. Accelerator discussion frame. Accelerator 3: community and civil society engagement. 2018. Available at: https://www.who.int/docs/default-
source/global-action-plan/accelerator3.pdf
49 Dain, K. A “whole of society” approach to non-communicable diseases must include civil society organisations. BMJ. 2019. Available at: https://blogs.
bmj.com/bmj/2019/12/06/a-whole-of-society-approach-to-non-communicable-diseases-must-include-civil-society-organisations/
50 NCD Alliance. Directory of national & regional NCD alliances. Available at: https://ncdalliance.org/what-we-do/capacity-development/directory-of-
national-regional-ncd-alliances
51 NCD Alliance. Bridging the Gap survey.
Lack of meaningful involvement  
of civil society and people living 
with NCDs
Given the size of the challenge of NCDs, governments 
have readily signed up to a whole-of-society approach 
that calls on all sectors to step up. The 2018 UN Political 
Declaration on NCDs specifically includes a commitment 
to “promote meaningful civil society engagement and 
amplify the voices of and raise awareness about people 
living with and affected by NCDs”. But to date, the specific 
role of civil society and people living with NCDs has been 
too absent from the political narrative, and efforts to 
engage civil society within health governance, planning, 
and accountability have been – at best – tokenistic at 
global and country levels.
A recent WHO survey shows that less than half of countries 
have multi-sectoral NCD commissions in operation, and 
that around one third of these do not include NGOs/
civil society. This echoes a recent NCD Alliance survey, 
which found that only one quarter of NCD alliances view 
local and national decision-making bodies as accessible 
to civil society organisations, including grassroots and 
patient organisations. While individual reasons may differ, 
the lack of mechanisms to engage civil society in decision 
making processes is considered by NCD alliances as one 
of the top three challenges limiting their work.51 
Involvement of PLWNCDs, communities with unique 
needs and strengths, and young people has also been 
broadly neglected and undervalued. Only 24% of 
national NCD alliances believe that their government’s 
policies, programmes and laws are inclusive enough to 
ensure that no one is left behind in the NCD response.
The UN and governments must walk the talk on their 
commitment to meaningful engagement of civil society. 
They need to move beyond tokenistic efforts and create 
truly inclusive processes at all levels of policy and 
programme design, governance and service delivery, 
and creation and implementation of accountability 
mechanisms to provide PLWNCDs and civil society with 
opportunities to engage and contribute as equal partners 
and experts in their own right. 
Shrinking space for civil society
NCD civil society has never been stronger and more 
unified. But the space in which civil society operates is 
increasingly being curtailed. Between 2012 and 2015, 
more than 120 laws restricting civic rights were introduced 
or proposed in 60 countries.52 These legislative 
changes53 are intended to undermine the effectiveness 
and independence of civil society actors, and restrict 
capacity to function and fulfil the role of challenging 
those in power to better deliver for the public good. 
52 Aho, Emilie and Grinde, Jonatan. Shrinking space for civil society – challenges in implementing the 2030 Agenda. 2017. Available at: https://www.
forumsyd.org/sites/default/files/2018-03/Shrinking-Space%20-%20Challenges%20in%20implementing%20the%202030%20agenda.pdf 
53 “Defamation laws, criminalisation of previously permitted activities, bans on organisations funded by foreign sources, branding civil society 
organisations as foreign agents, and strict media reporting regulations are among just some of the legal measures that limit, or in some cases entirely 
suppress, civil society.” (Aho Emilie et al.).
54 UNAIDS. How AIDS Changed Everything. 2015. Available at: https://www.unaids.org/sites/default/files/media_asset/MDG6Report_en.pdf
Sustainable financing for NCD 
civil society
More investment is urgently needed to support CSOs 
and community systems, particularly in LMICs. This is a 
valuable lesson from the AIDS response54, with donors 
including the Bill and Melinda Gates Foundation and the 
Ford Foundation stepping in to channel funds to support 
CSOs and build skills in advocacy, budget tracking, and 
documenting best practice to professionalise the sector 
and deliver faster progress. 
According to a recent NCD Alliance survey, financial 
constraints remain the number one challenge limiting 
the response across the global network of national 
and regional NCD alliances. There are few or no public 
resources available to NCD alliances in LMICs, and many 
NCD alliances lack capacity to effectively fundraise. To 
date, very few national or regional alliances have been 
able to mobilise international development funding, 
largely due to the lack of NCD-specific funds available. 
Twinning initiatives between HIC and LIC alliances have 
remained the exception, and the grants administered via 
the NCD Alliance Advocacy Institute have been small but 
vital to seeding newly founded alliances, and to scale-up 
the work of existing alliances.
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The UN NCD response includes established 
monitoring processes – the WHO Global 
NCD Action Plan and Monitoring Framework 
on NCDs, the 2014 UN Review Outcome 
Document, the Sustainable Development 
Goals and the UN Monitoring Framework for 
the SDGs, as well as WHO’s regular Progress 
Monitor Reports, Country Profiles and 
Country Capacity Surveys. Still, the glaring 
gap between global commitments and 
national implementation of effective policies 
suggests that leaders and governments 
are not sufficiently held accountable for 
delivering on the targets. 
 
55 WHO. Tackling NCDs: ‘best buy’ and other recommended interventions for the prevention and control of noncommunicable diseases. World Health 
Organization. 2017. Available at: https://apps.who.int/iris/handle/10665/259232 (accessed 16 December 2019).
56 WHO. Noncommunicable diseases country profiles. 2018. Available at: https://www.who.int/nmh/publications/ncd-profiles-2018/en
57 According to Allen et al, between 2015 and 2017, aggregate implementation scores rose in 109 countries and regressed in 32 countries. Mean 
implementation rose for all of the 18 policies except for those targeting alcohol and physical activity.
58 WHO. Noncommunicable diseases progress monitor. 2017. Available at: https://www.who.int/nmh/publications/ncd-progress-monitor-2017/en/ 
Accountability is a crucial force for political and 
programmatic change, and key to tracking progress 
on NCDs. Defined as a cyclical process of monitoring, 
review and action, accountability enables the tracking 
of commitments, resources, and results and provides 
information on what works and why, what needs 
improving, and what requires increased attention. 
Accountability ensures that decision makers have the 
information required to meet the health needs and realise 
the rights of all people at risk of or living with NCDs, and 
to place them at the heart of related efforts.
Implementation lags behind the 
evidence, and the economics
Implementing all 16 WHO-recognised ‘best buy’55 – 
globally recommended, evidence-based, highly cost-
effective policy interventions – would prevent 9.6 million 
premature deaths worldwide between 2018 and 2025.56 
While implementation of recommended NCD policies 
is slowly increasing,57 on average just under half of the 
recommended policies have been implemented in-
country.58 The least implemented of these highly impactful 
and cost-effective policies are tobacco taxation, tobacco 
mass media campaigns, provision of cardiovascular 
therapies, and alcohol advertising restrictions, revealing 




Call for and participate in inclusive NCD governance mechanisms, institutionalising  
the role of PLWNCDs and civil society in health decision-making at national, regional and 
international level
Learn from the AIDS response as a pioneer in establishing inclusive governance mechanisms. For 
example, NGOs are represented on the boards of the Global Fund, and civil society and PLWHIV are 
specifically included in the governance structure of UNAIDS.
Communicate effectively by leveraging outrage, rebuking injustice, translating evidence, 
sharing personal stories, celebrating successes, and campaigning collaboratively 
Mobilise for the annual Global Week for Action on NCDs and other milestone days, weeks and political 
campaigns to use diverse communication strategies. Use traditional and social media to make noise, 
demand change, and put issues, insights and solutions in front of policy makers.
Coordinate civil society action across all SDGs
It is essential that CSOs across different sectors work more closely together, to ensure that there are no 
trade-offs between the different aspects of sustainable development. 
Team up with legal experts to explore how a rights angle could accelerate NCD action 
Explore how binding legal instruments and treaties can advance the NCD agenda, including legal 
measures against governments for failure to meet commitments to rights and equity.
Join forces with social movements representing people left behind, including environment  
and equity advocates, youth movements, indigenous communities and others advocating 
systemic reform 
In addition to the strong links already forged with child rights, women’s health and HIV/AIDS movements, 
NCD civil society can make a common cause with campaigners for environment, climate, and others who 
campaign for wellbeing to be put ahead of short-term economic indicators in decision making. Ensure that 
social and environmental policies are also understood as health and wellbeing policies. 
Celebrate and share successes
‘Yes We Can’ is a legendary political slogan that inspired a movement to believe that unprecedented 
change was possible, becoming a self-fulfilling prophecy. Showcasing successful and courageous NCD 
actions and leaders who implement effective measures can encourage and inspire others to emulate 
these successes for their own countries and people
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A recent systematic analysis59 of the impact of 
geopolitical and economic factors60 on NCD policy 
responses highlights that gross national income is not 
the decisive factor in policy implementation. Leaders’ 
willingness to invest in human capital by improving health 
and education may be a more important prerequisite 
than national wealth itself. 
In LMICs alone, where action is most urgently needed, 8.1 
million premature deaths could be avoided between 2018 
and 2030, representing a reduction of almost 15% in total 
premature mortality from NCDs.61 In LMICs, implementing 
the ‘best buy’ policies would require an investment of 
US$1.27 per person per year between now and 2030, 
and generate an economic return of seven dollars per 
dollar spent62. In the case of fiscal measures, the ‘best 
buy’ generate government revenue which could be 
reinvested in UHC, providing a double dividend for health 
and the economy by reducing the burden of disease and 
providing resources for health. 
National accountability 
mechanisms and action
Accountability mechanisms, data collection and 
surveillance systems are crucial to fill the gap between 
promises, plans and effective implementation. A 2018 
analysis63 of NCD policy processes in five African 
countries64 shows that while all countries had recently 
developed NCD strategic plans, these had not been 
adequately implemented due to inadequate political 
commitment and a lack of resources and technical 
capacity, as well as industry influence. 
This is echoed by NCD Alliance’s survey findings: 
Although 62% of countries have indicators for national 
NCD targets, currently, only 18% of NCDA survey 
respondents believe that their country has sufficient 
accountability mechanisms to ensure the targets are 
actually met. 
59 Allen, Luke N.; Nicholson, Brian D.; Yeung, Beatrice Y.T.; Goiana-da-Silva, Francisco. Implementation of non-communicable disease policies: a 
geopolitical analysis of 151 countries. December 2019.
60 These factors are: region, NCD burden, human and financial resources (i.e. personal wealth, tax burden), political ideology, and social solidarity.
61 WHO. Saving lives, spending less: a strategic response to noncommunicable diseases. 2018. Available at: http://www.who.int/ncds/management/ncds-
strategic-response/en/
62 Ibid.
63 Juma P.A.; Mohamed S.F.; Matanje Mwagomba B.L.; et al. Non-communicable disease prevention policy process in five African countries authors. BMC 
Public Health. 2018. 961. 
64 Kenya, South Africa, Cameroon, Nigeria, Malawi.
Data for the forthcoming WHO Progress Monitor report 
shows that an encouraging 84% of Member States report 
funding allocated from national budgets toward NCD 
surveillance, monitoring and evaluation. But in reality 
this is insufficient, as only around one fifth of national 
NCD alliances believe their country’s NCD surveillance, 
monitoring and evaluation capacity is adequate. This 
underlines the urgent need to hold governments 
accountable to their 2018 Political Declaration 
commitment to establish or strengthen transparent 
national accountability mechanisms.
Whilst significant improvements have been achieved in 
terms of strengthening accountability for NCDs at the 
global level, follow-up is needed at the most relevant 
political level. For national or regional politicians, the non-
binding 2025 and 2030 NCD targets are rarely discussed 
in national media or political debate, so have not been 
rendered politically salient outside of international fora 
such as the World Health Assembly or UN General 
Assembly. Politicians typically prioritise short-term 
domestic wins – like economic growth, improvements 
in quality of life, national security – within the current 
political cycle, with the aim of securing re-election.
NCDs receive attention when the public and politicians 
understand that this preventable epidemic costs them 
dearly – including in terms of votes – and requires the 
highest level of government leadership and coherence 
across sectors. Public awareness and pressure are 
crucial, especially where commercial actors are lobbying 
to undermine public health policies that could challenge 
their business interests. 
Progress requires comprehensive national NCD 
surveillance systems, including reliable registration of 
deaths by cause, disaggregation of data by gender, age, 
and socio-economic status, cancer registration, periodic 
data collection on risk factors, and monitoring of national 
responses. 
Independent accountability –  
the opportunities
Existing WHO, UN and national accountability 
mechanisms for NCDs can be complemented by 
independent accountability mechanisms and initiatives 
at global, regional and country level. Independent (non-
governmental) accountability exercises undertaken 
by civil society organisations are important to hold 
governments to account for their commitments, and ensure 
that they translate into real action and NCD progress. The 
results of independent evaluations are useful tools – an 
external assessment, index or ranking can often spur 
action by governments shown to be lagging behind or 
not measuring up to their peers’ progress. 
Civil society is a vital actor in independent accountability, 
due to its proximity to the affected communities and 
independence from government and vested interests. 
One third of NCD alliances are engaged in accountability 
activities or mechanisms to monitor and evaluate the 
progress of NCD policies, programmes and laws in their 
country or region. Diverse and inclusive NCD Alliances 
and coalitions’ monitoring and shadow reporting can 
improve awareness and accountability at the national 
level. These processes can help support, complement 
or challenge government narratives, engage the media 
and influence public opinion by publicly communicating 
findings, and consolidate advocates’ position as trusted 
civil society voices on NCDs.
65 NCD Countdown 2030 is an independent collaboration between WHO, The Lancet, NCD Alliance, the WHO Collaborating Centre on NCD 
Surveillance and Epidemiology at Imperial College London, and researchers and practitioners from all regions. The initiative aims to inform policies 
that aim to reduce the worldwide burden of NCDs, and to ensure accountability.
66 “probability of dying from any NCD between birth and 80 years of age”.
NCD Alliance’s Accountability Toolkit (2020)
provides many examples and highlights actions 
of the NCD community in several countries, 
including producing Civil Society Status Reports 
on progress towards national targets.
One example of independent accountability at global 
level is NCD Countdown 203065, which helps fill gaps in 
reporting on progress towards SDG target 3.4 on NCD 
mortality, risk factor prevalence, and relevant health 
system interventions. Using a more comprehensive 
mortality indicator66 than the global WHO and UN 
NCD accountability framework, NCD Countdown has 
shown that NCD mortality estimates are conservative, 
particularly in LMICs, shedding new light on the true 
burden of NCDs on societies and economies. 
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Next steps
This paper is intended as a basis for future discussion within and beyond the NCD community to tackle the gaps 
in the first decade of the NCD response. The gaps described above are all closely interconnected and action 
will be needed across the whole spectrum to address them. The Civil Society Compass outlines suggestions for 
NCD civil society to accelerate the response towards 2025 and 2030, and to bridge the gap between global 
commitments and effective action to prevent and treat NCDs in every region and every country. We invite civil 
society organisations to take up these ideas, adapt them appropriately to their local context, and propose their 
own actions in response to the challenges they face. We look forward to feedback on the gaps identified and 
actions suggested here, and to using this feedback as a foundation for future action together, in order to overcome 
the neglect of NCDs and accelerate overdue progress.
Bridging the Gap on NCDs
Increase independent accountability, produce Civil Society Status Reports and make NCDs 
an election issue
The NCD Alliance Accountability Toolkit (2020) can be used to guide an assessment of national or 
regional progress in achieving NCD-related goals and targets. Civil society accountability exercises 
facilitate opportunities to understand, celebrate and challenge the factors driving progress and gaps in 
NCD policy implementation, and ensure NCDs are election issues. 
Focus on bitesize targets and milestones with 2030 in sight, while advocating that, by 
2025, all countries are regularly monitoring progress on national NCD targets  
and indicators
The NCD SDG 3.4 target can be broken down into ‘bitesize’ milestone targets. The 25% relative reduction 
target in premature mortality from NCDs by 2025 and corresponding nine global voluntary targets are 
viable, focused and incremental stepping stones to 2030.
Engage and support champions
Identifying, engaging and supporting persistent champions and strong advocates from civil society and 
within government, who are able to communicate compelling narratives based on both scientific and 
community evidence that appeal to policy-makers and the public alike, can catapult NCDs to become 
high-level domestic priorities.
Expand future NCD Countdown 2030 reporting 
This reporting should include implementation of multi-sectoral policies and financial commitments by 
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This paper outlines the gaps in the first decade of the NCD response. 
Calling on the experience of NCD Alliance’s global network of people 
living with NCDs, advocates, campaigners and experts collected via 
several surveys, as well as the latest data from the World Health 
Organization and peer reviewed literature, this paper identifies what 
has been lost in translation of the global targets for NCD reduction and 
describe the major barriers to meaningful progress.
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